Dr. Erik Hornes serves as Chief Executive Officer and Director of R&D for Genpoint AS, a subsidiary of NorDiag ASA from 2006 to March 2007. Dr. Hornes served as Chief Scientific Officer and Vice President of Technology Development at Life Technologies AS from 2003 to 2004. He served as the Chief Scientific Officer of NorDiag ASA. Furthermore he co-founded, and acted as Chief Scientific Officer of GenoVision from 1998 to 2003 and Dynal Biotech from 1992 to 1998. He also was employed at Alpharma from 1983 to 1992. Dr. Hornes serves as Director of PlasmAcute AS. He holds PhD from the University of Oslo.